Oracle Health Services, a division of Oracle Corporation, announced its participation with The Opportunity Project (TOP) Technology Sprint: Creating the Future of Health to match patients more effectively with clinical trials and experimental therapies, the company announced on Monday.
The company’s involvement will utilize artificial intelligence (AI) and machine learning (ML) to standardize data from clinical trial requirement forms to specific eligibility criteria, enable intuitive interfaces that provide data at point of care and track patient care to determine the best treatment for patients.
Patients would be able to retain their privacy, identity and receive information and therapy that’s relevant to their treatment. Clinical trial participants will be provided through de-identified precision oncology open data sets from the National Cancer Institute and the U.S. Department of Veterans Affairs (VA).
Steve Rosenberg, senior vice president and general manager said, “It is paramount that we collaborate with our peers within the federal government and technology communities to collectively evaluate what innovative opportunities exist and to explore the potential applications AI and machine learning can offer to fight deadly diseases such as cancer.”
TOP is a 12-week technology development effort involving both private enterprise and government to solve real-world problems using open data. TOP will host its Demo Day 2019 on December 10, 2019 at the U.S. Census Bureau in Suitland, MD.
About Oracle Health Sciences
Oracle Health Sciences breaks down barriers and opens new pathways to unify people and processes to bring new drugs to market faster. As a leader in Life Sciences technology, Oracle Health Sciences is trusted by 30 of the top 30 pharma, 10 of the top 10 biotech and 10 of the top 10 CROs for managing clinical trials and pharmacovigilance around the globe.
About Oracle
The Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.
